Cumberland Pharmaceuticals (CPIX) EPS (Diluted) Growth (3y) (2013 - 2026)
Cumberland Pharmaceuticals (CPIX) EPS (Diluted) Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 15.17% |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 3.25% |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 2.66% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 11.56% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -35.09% |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 13.29% |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 36.48% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 116.48 Mn | 112.62 Mn | - | -89.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -49.16% |
| Mar 31, 2026 | -170.43% |
| Dec 31, 2024 | -81.76% |
| Sep 30, 2024 | -74.09% |
| Jun 30, 2024 | -63.44% |
| Mar 31, 2024 | -83.24% |
| Dec 31, 2023 | -112.99% |
| Sep 30, 2023 | -51.09% |
| Jun 30, 2023 | 6.92% |
| Mar 31, 2023 | -39.19% |
| Dec 31, 2021 | 27.81% |
| Sep 30, 2021 | 32.24% |
| Jun 30, 2021 | 39.15% |
| Mar 31, 2021 | 30.32% |
| Dec 31, 2020 | 46.02% |
| Sep 30, 2020 | 45.45% |
| Jun 30, 2020 | 29.06% |
| Mar 31, 2020 | 250.29% |
| Dec 31, 2019 | 74.17% |
| Sep 30, 2019 | 147.58% |